William Gastle - Microbix Biosystems Chairman
| MBX Stock | CAD 0.29 0.01 3.33% |
Chairman
Mr. William J. Gastle is Executive Chairman of the Board of the Company. He resigned as Chief Executive Officer of the company effective November 20, 2012. Mr. Gastle is the founder of Microbix and has served as a Director since its inception. Mr. William J. Gastle has an MSc. and was the CEO of Microbix since 1990 and has had responsibility for Microbix financial statements since the Company became public Company in 1990. He is Chairman of the Board of Directors and has attended all Audit Committee since 1990 in his role as either a senior manager or as a Member. Mr. Gastle has an M.Sc. in Microbiology from the University of Toronto. He earned his B.Sc. with Honours in Biology and Biochemistry from Dalhousie University, Halifax . since 2012.
| Tenure | 13 years |
| Phone | 905 361 8910 |
| Web | https://www.microbix.com |
Microbix Biosystems Management Efficiency
The company has return on total asset (ROA) of 0.0327 % which means that it generated a profit of $0.0327 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0532 %, meaning that it generated $0.0532 on every $100 dollars invested by stockholders. Microbix Biosystems' management efficiency ratios could be used to measure how well Microbix Biosystems manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 4 records | CHAIRMAN Age | ||
| Jacek Antas | Helix BioPharma Corp | N/A | |
| Dawn Svoronos | Theratechnologies | 65 | |
| Artur Gabor | Helix BioPharma Corp | 62 | |
| Wayne Pisano | Oncolytics Biotech | 64 | |
Management Performance
| Return On Equity | 0.0532 | |||
| Return On Asset | 0.0327 |
Microbix Biosystems Leadership Team
Elected by the shareholders, the Microbix Biosystems' board of directors comprises two types of representatives: Microbix Biosystems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Microbix. The board's role is to monitor Microbix Biosystems' management team and ensure that shareholders' interests are well served. Microbix Biosystems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Microbix Biosystems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Cochran, Independent Director | ||
| Philip Casselli, Senior Vice President - Business Development and Sales, Marketing | ||
| Kevin Cassidy, Senior Vice President Sales and Business Development | ||
| William Gastle, Founder, Executive Chairman, Member of Audit Committee and Member of HR, Compensation and Governance Committee | ||
| Mark Luscher, Senior Vice President - Scientific Affairs | ||
| Christopher Lobb, General Officer | ||
| Joseph Renner, Lead, Independent Director | ||
| Kathryn Froh, Vice President - Diagnostics | ||
| Martin Marino, Independent Chairman of the Board | ||
| Cameron Groome, President, Chief Executive Officer, Director | ||
| James Currie, Chief Financial Officer | ||
| Vaughn EmbroPantalony, President CEO, Director | ||
| Kenneth Hughes, Chief Operating Officer | ||
| Peter Blecher, Independent Director |
Microbix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Microbix Biosystems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Pair Trading with Microbix Biosystems
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbix Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbix Biosystems will appreciate offsetting losses from the drop in the long position's value.Moving against Microbix Stock
| 0.86 | MSFT | Microsoft CDR | PairCorr |
| 0.86 | MSFT | Microsoft Corp CDR | PairCorr |
| 0.84 | ARTG | Artemis Gold Earnings Call This Week | PairCorr |
| 0.82 | NVDA | NVIDIA CDR | PairCorr |
| 0.82 | NVDA | Nvidia CDR | PairCorr |
The ability to find closely correlated positions to Microbix Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbix Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbix Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbix Biosystems to buy it.
The correlation of Microbix Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbix Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbix Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microbix Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.